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Cancer-associated fibroblasts (CAFs) are the major cellular stromal component of many solid tumors. In 
prostate cancer (PCa), CAFs establish a metabolic symbiosis with PCa cells, contributing to cancer 
aggressiveness through lactate shuttle. In this study, we report that lactate uptake alters the NAD+/NADH ratio 
in the cancer cells, which culminates with SIRT1-dependent PGC-1α activation and subsequent enhancement 
of mitochondrial mass and activity. The high exploitation of mitochondria results in tricarboxylic acid cycle 
deregulation, accumulation of oncometabolites and in the altered expression of mitochondrial complexes, 
responsible for superoxide generation. Additionally, cancer cells hijack CAF-derived functional mitochondria 
through the formation of cellular bridges, a phenomenon that we observed in both in vitro and in vivo PCa 
models. Our work reveals a crucial function of tumor mitochondria as the energy sensors and transducers of 
CAF-dependent metabolic reprogramming and underscores the reliance of PCa cells on CAF catabolic activity 
and mitochondria trading. 
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Fibroblasts are the major constituent of the stromal compartment of many solid cancers, and their activation 
to a cancer-associated fibroblast (CAF) phenotype contributes to tumor initiation and progression. We and 
others have showed that CAFs sustain tumor progression by reprogramming cancer cell metabolism [1, 2]. In 
PCa, both CAFs and tumor cells undergo a reciprocal metabolic reprogramming and establish a symbiotic 
relationship. CAFs are converted to aerobic glycolysis when in contact with cancer cells, that reprogramme to 
oxidative phosphorylation (OXPHOS) upon CAF-released lactate upload via the monocarboxylate transporter 
1 (MCT1). Lactate-driven conversion of PCa cells to OXPHOS is sustained by the nuclear translocation of 
pyruvate kinase isoform M2 (PKM2), where it acts as a transcriptional regulator [3]. CAF-induced dependence 
on mitochondrial respiration of cancer cells further confers chemotherapy resistance [4], promotes redox-
dependent epithelial-to-mesenchymal transition (EMT) and increases metastatic burden [3]. 
It is now emerging that mitochondria are essential in cancer initiation and progression [5] and 
consequently OXPHOS has been associated with metastatic potential and resistance to therapy in many cancers 
[4, 6, 7]. Additionally, important mitochondrial metabolism regulators like the transcriptional coactivator 
peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC1-α) have been reported to support 
metastatic dissemination in melanoma and breast cancer [8]. However, mitochondrial metabolism has been 
also described to be detrimental in a model of prostate tumor progression [9], highlighting that 
microenvironmental cues and stromal cells within the tumor microenvironment can be crucial to better 
understand the role of this fascinating organelle. In this context, the transfer of ‘intact’ functional mitochondria 
and/or mitochondrial DNA (mtDNA) from stromal to cancer cells has been reported to proficiently restore 
OXPHOS in mtDNA-deprived cancer cells, hence re-establishing tumor-initiating efficacy [10-13]. 
Here, we investigate how CAFs regulate mitochondrial dynamics in PCa cells. Crucially, we 
demonstrate that molecular and metabolic inputs generated by CAFs are sensed by the SIRT1/PGC-1α axis of 
the cancer cells that lead to mitochondria reshape. Additionally, we provide evidence that CAFs donate their 
dispensable but functional mitochondria to the cancer cells leading to an enhancement of their malignant 
phenotype. Understanding the role of mitochondria in this PCa model of metabolic symbiosis offers an 
opportunity to eventually target tumor:stroma co-evolution and co-operation.  
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CAF contact activates SIRT1/PGC-1α and potentiates mitochondrial metabolism in PCa cells 
To investigate the molecular players involved in the metabolic conversion of PCa cells towards OXPHOS, we 
initially focused on sirtuins (SIRTs), NAD+-dependent deacetylases that act as sensors of nutrient availability, 
whose expression being increased upon nutrient deprivation [14, 15]. Indeed, after 24 hours of PC3 cells 
exposure to CAF-conditioned medium (CM), we observed a significant increase in NADH levels (Fig. 1A, 
left) compared to HPF-CM-treated cells, possibly due to the oxidation of the lactate present in the CAF-CM. 
After 48 and 72 hours NADH levels return to basal, whereas NAD+ levels increase (Fig. 1A, right and Fig. 
S1A), as a consequence of electron transport chain (ETC) enhanced activity. Notably, the NAD+ and NADH 
levels were unaffected when cancer cells were exposed to CM from healthy human prostate fibroblasts (HPFs). 
SIRTs expression has been previously reported to be dependent on the NAD+/NADH ratio [16]. Accordingly, 
western blot analysis revealed a rapid NADH-dependent increase in SIRT1 expression levels (Fig. 1B) and 
subsequent NAD+-dependent SIRT1 activation at 48 and 72 hours after CAF-conditioning, as revealed by the 
deacetylation of PGC-1α (Fig. 1B), a regulator of mitochondrial biogenesis and OXPHOS [17] that is an 
established target of SIRT1 [18]. The link between SIRT1 activity and PGC-1α deacetylation (i.e. activation) 
is supported by the negative correlation between NAD+ levels and PGC-1α acetylation status (rs=-0.49; 
P<0.0001) (Fig. 1C) and further strengthened by the impairment of CAF-induced PGC-1α deacetylation upon 
SIRT1 silencing (Fig. S1B). The relevant role of lactate in mediating the early rise of NADH levels (24 hours) 
upon CAF-CM administration was reinforced by the inhibitory effect exerted by the inward lactate transporter 
MCT1 inhibitor (AR-C155858) and by the ability of exogenous lactate administration to resemble CAF 
conditioning (Fig. 1D). We also observed that lactate was the only metabolite that was able to induce a 
significant SIRT1 overexpression (Fig. 1E) and that lactate-induced SIRT1 upregulation and PGC-1α 
deacetylation were impaired by preventing lactate upload by cancer cells (Fig. 1F), highlighting an additional 
role of lactate beyond its function as a nutrient.  
The CAF-mediated activation of the SIRT1/PGC-1α axis has a clear impact on mitochondrial 
metabolism, has revealed by the increase in mitochondrial activity in both CAF-CM exposed PC3 and DU145 
cells, as revealed by FACS and confocal analyses (Fig. 2 A-B). Notably, CAF conditioning induce a significant 
increase in mitochondrial mass (Fig. 2C), which likely contributes to the improvement of the overall 
mitochondrial metabolism. These observation were corroborated by an increase in oxygen consumption rate 
(OCR) (Fig. 2D), confirming the role of CAFs in promoting PCa cells mitochondrial respiration. To investigate 
the impact of CAF-mediated mitochondrial reprogramming on the tricarboxylic acid (TCA) cycle, PC3 cells 
exposed to CAF-CM or to HPF-CM were subjected to liquid chromatography mass spectrometry (LC-MS) 
(Fig. 2E). Comparative analysis revealed a significant increase of citrate, succinate, fumarate and malate 
content in CAF-conditioned samples (Fig. 2E), whereas α-ketoglutarate (α-KG) and 2-hydroxyglutarate levels 
were unaffected by CAF exposure. 
CAF-induced SIRT1/PGC-1α activation drives PCa cell invasion  
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Mitochondrial biogenesis and PGC-1α-dependent OXPHOS metabolism are implicated in breast cancer cell 
motility and metastasis [8, 10]. Therefore, we investigated whether CAF-induced mitochondrial enhancement 
is associated with PCa cells invasiveness. SIRT1 silencing impaired the ability of PC3 cells to undergo EMT 
(Fig. 3A) and to invade (Fig. 3B) following CAF conditioning. Additionally, SIRT1 silencing impaired CAF-
induced hypoxia inducible factor-1α (HIF-1 stabilization in PC3 and DU145 cells (Fig. 3A), a well-known 
CAF-induced malignant feature of PCa cells [3, 19]. Similar results were obtained in DU145 cells (Fig. S1C). 
CAF-induced EMT and invasive abilities of PC3 cells (Fig. 3C-D), as well as their mitochondrial improvement 
(Fig. 3E), were also negatively affected by PGC-1α silencing. The importance of the SIRT1/PGC-1α pathway 
in sustaining the CAF-induced mitochondrial function improvement was strengthened by the negative impact 
of SIRT1 and PGC-1α silencing on the oxygen consumption rate (Fig. 3F and Fig. S1D). The impairment of 
SIRT1 upregulation also prevented TCA cycle rearrangement and the accumulation of citrate, succinate, 
fumarate and malate upon CAF-CM exposure (Fig. 3G). 
CAF-induced TCA cycle deregulation affects HIF-1α activation, sustaining PCa cells invasion 
Succinate and fumarate accumulation has been already reported to competitively inhibit α-KG-dependent 
prolyl hydroxylases (PHD), thereby stabilizing HIF-1α in SDH- and FH-deficient cells [20]. Similarly, among 
the electron transport chain (ETC) components, we found decreased succinate dehydrogenase (SDH) 
expression (i.e. complex II, Fig. 4A) and enzymatic activity (Fig. 4B) in CAF-treated PC3 cells. Interestingly, 
the downregulation in Complexes II-III, concomitant with Complex I increased expression (Fig. 4A), which 
are involved in redox homeostasis and mitochondrial reactive oxygen species (mtROS) generation, suggests 
that CAFs could promote ETC dysfunction and subsequent mitochondrial metabolic reprogramming in PC3 
cells.  
We previously reported that CAF-induced HIF-1α stabilization and activation in PC3 cells occurs in 
normoxic condition [19].  Thus, we investigated whether CAF-driven lactate entry and its mitochondrial 
exploitation (via succinate accumulation) could be involved in promoting HIF-1 levels through 
pyruvate/succinate competitive actions linked to PHDs inhibition [21]. Crucially, inhibiting lactate import by 
using the MCT1 inhibitor reverted CAF-CM-induced HIF-1α stabilization in cancer cells (Fig. 4C). Similarly, 
administration of α-KG as succinate competitor prevented CAF-CM-induced HIF-1α stabilization and 
transcriptional activation in PC3 cells (Fig. 4D-E), ultimately impairing CAF-induced EMT and invasion (Fig. 
4G-H). 
mtROS generation sustains the pro-invasive features induced by CAF exposure in PCa cells 
Dysfunctional mitochondrial activity and/or high exploitation of mitochondrial respiration lead to enhanced 
mtROS accumulation that regulate cellular proliferation, migration and invasion [22-24]. As detected by FACS 
and confocal analysis, both PC3 and DU145 cells exposed to CAF-CM showed a significant increase in mtROS 
(Fig. 5A and Fig. S2A). Notably, mitoTEMPO administration, a specific scavenger of mitochondrial 
superoxide [25, 26], was able to interfere with CAF-induced EMT (Fig. S2B) and invasive abilities of PCa 
cells (Fig. 5B), thus suggesting mtROS as key drivers of the observed CAF-induced tumor cell aggressiveness. 
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mtROS induce pro-migratory signals and metastasis via different pathways activation [24, 27] 
including that of the redox-sensitive tyrosine kinase Src [24]. Moreover, we have previously reported that Src-
dependent PKM2 phosphorylation drives PCa cells reprogramming upon CAF-conditioning [3, 28]. Therefore, 
we analyzed Src and PKM2 redox state after CAF-conditioning, in the presence or absence of mitoTEMPO. 
Our results indicate that both enzymes undergo a strong oxidation after CAF exposure, which was prevented 
by mitoTEMPO (Fig. S2C). As Src oxidation (i.e. activation) has been reported in supporting CAF-induced 
lactate-addiction of PCa cells [3], we approached SIRT1/PGC-1α pathway by using two redox-insensitive Src 
mutants (Src C245A and C487A) [28]. Both non-oxidable Src mutants effectively impaired the lactate-
dependent NADH/NAD+ unbalance observed upon CAF-CM administration in PC3 cells (Fig. 5C and S2D). 
The non-oxidable Src mutants also impairs the CAF-induced SIRT1 increased expression and activity, 
monitored by PGC-1α deacetylation (Fig. 5D). Similarly, SIRT1 silencing impaired CAF-induced mtROS 
generation in PC3 cells, possibly altering cancer cells ability to sense the CAF-released lactate (Fig. 5E).  
CAFs transfer mitochondria to PCa cells further enhancing their metabolic and motile features 
We next analyzed the possibility that stroma influence mitochondrial/metabolic tumor cell behavior through 
an exogenous way, that is an horizontal transfer of mitochondria. For this goal, CAFs mitochondria were 
transiently labeled with MitoTracker Green and incubated with unlabeled PC3 or DU145 cells. Confocal 
analysis of coculture showed that PCa cells became positive for mitochondrial staining, suggesting the 
acquisition of stromal-derived mitochondria (Fig. 6A-B). The ability of mitochondrial transfer is a specific 
feature of the cancer-reprogrammed highly glycolytic CAFs [2], since the healthy counterpart (HPFs) are not 
able to donate their own mitochondria to PCa cells (Fig. S3A). In addition, no transfer of stained mitochondria 
was revealed from PC3 towards unlabeled CAFs, highlighting a specific unidirectional transfer of 
mitochondria from CAFs to PC3 cells (data not shown).  
CAF mitochondria transfer to PC3 cells was also confirmed in coculture between differentially labeled cells 
(PC3 cells stably expressing the red fluorescent protein tdTomato-PC3Tom, and CAFs with MitoTracker 
Green-prelabelled mitochondria). FACS analysis revealed a red and green double staining of PC3 cells, 
confirming the transfer of green-fluorescent mitochondria to red-fluorescent PC3 cells (Fig. 6C). To exclude 
that the staining of PC3 cells was due to dye leakage from CAFs, we alternatively established cocultures 
between GFP-transfected PC3 cells and CAFs transfected with a plasmid encoding a mitochondrial-targeted 
fluorescent protein (MitoDsRed). Indeed, we confirmed that MitoDsRed stained-mitochondria are proficiently 
transferred from CAFs to GFP-labelled PC3 cells (Fig. 6D). Notably, we also demonstrated that both 
endogenous tumor cell mitochondria and exogenously acquired mitochondria from MitoGFP-labelled CAFs 
have a functionality-associated fluorescent signal (Fig. 6E), suggesting that CAFs increase PCa cell respiratory 
capacity not only by enhancing the activity of cancer cell endogenous mitochondria (via the SIRT1/PGC-1α 
pathway), but also by recruiting functional mitochondria from symbiotic stromal cells.  
To investigate whether PCa cells in vivo recruited mitochondria from CAFs, we established tumor 
xenografts in immunodeficient SCID-bg/bg mice by subcutaneously injecting either unlabeled or PC3Tom 
cells together with unlabeled or MitoGFP-expressing CAFs, respectively (Fig. 7A). After 25 days, tumors 
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were excised and disaggregated for cell recovery. Tumors from different groups were weighed after excision 
to ensure that the expression of fluorescent proteins did not interfere with cell growth in vivo. To detect the in 
vivo transfer of MitoGFP-labelled mitochondria from CAF donor cells to PC3 receiving cells, PC3Tom cells 
recovered by tumors excised by animals single-injected with PC3Tom or co-injected with PC3Tom + 
mitoGFP-CAFs, were analyzed by FACS and confocal microscopy. A significant enrichment in mitoGFP-
stained PC3Tom cells, due to the acquisition of CAF-released mitoGFP-labelled mitochondria (Fig. 7B-C) 
was revealed, highlighting the importance of the unidirectional mitochondrial transfer in vivo.  Furthermore, 
by analyzing PC3 cells isolated from tumors excised by animals injected with unlabeled cells (PC3 single 
injection or PC3 + CAF co-injection), we observed an increase in both the overall mitochondrial content, 
measured by MitoTracker Green staining, (Fig. 7D-E) and functionality, analyzed by TMRE staining (Fig. 
7F), upon in vivo CAF interaction. These metabolic data were also supported by the higher expression of 
MCT1 and SIRT1 and the downregulation of E-cadherin, observed in PC3 cells in vivo interacting with CAFs 
with respect to PC3 cells alone (Fig. 7G), in keeping with their lactate exploitation, OXPHOS addiction and 
EMT execution. 
In order to evaluate whether in vivo higher grade of malignancy correlates with an increase in lactate 
exploitation, we analyzed explants from patients affected by clinically localized well differentiated 
adenocarcinoma (grade group 1) or low differentiated PCa with extension in the seminal vesicle and metastasis 
in the lymph-nodes and low differentiated adenocarcinomas (grade group 3). We observed a significantly 
higher expression of MCT1 and SIRT1 high grade tumors, while low levels of both the proteins are expressed 
in the low grade tumors (Fig. 7H). These in vivo evidence reinforce our conclusion about the role of MCT1-
dependent lactate influx and the activation of the SIRT1-mediated enhancement of mitochondrial metabolism 
in conferring more malignant traits, likely contributing to the improvement of metastatic potential. 
It has been reported that mitochondrial transfer can occur by endocytosis, exosomes [29] or via cytoplasmic 
bridges, also known as tunneling nanotubes [30], that allow the transfer of mitochondria from adjacent cells 
[31-33]. Intriguingly, confocal images obtained during co-culture of PC3 cells with MitoGFP-transfected 
CAFs indicated the formation of physical connection between stromal and tumor cells with labelled 
mitochondria located within these cellular bridges, leading to the transfer of mitochondria from CAFs to PCa 
cells (Fig. 8A-B). To evaluate the impact of stromal transferred mitochondria on PC3 cells, green fluorescent 
mitochondria from CAFs were isolated, and administrated to tumor cells, upon confirming their functionality 
by OCR analysis (data not shown) (Fig. 8C). Representative images showed that PC3 cells significantly upload 
exogenous mitochondria, whereas CAFs are not able to act as recipient cells, suggesting a characteristic feature 
of PC3 cells to acquire mitochondria from outside (Fig. 8D, left). We also observed that PC3 cells exposed to 
CAF-CM are more prone to incorporate isolated mitochondria, as also reported by the quantification analysis 
(Fig. 8D, right). Particularly, z-stack-confocal imaging of a representative receiver cancer cell and the 
associated 3D reconstruction clearly demonstrated that the cancer cells (red fluorescent) have incorporated 
intact green-stained mitochondria (Fig. 8E, Video 1).  
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We next investigated whether the observed mitochondrial transfer impacts on CAF-dependent PCa 
cell phenotype and aggressive features. Indeed, we exposed cancer cells to mitochondria isolated from 
MitoGFP-transfected CAFs and we measured mtROS production upon CAF-CM or HPF-CM exposure (Fig. 
8F). As previously shown, mtROS production is enhanced in CAF-CM treated PC3 cells (Fig. 8F, black vs 
red bars), but, interestingly, the fraction of cells acquiring CAF mitochondria (MitoGFP+) displayed a further 
enhancement in MitoSOX staining, compared to MitoGFP- cells (Fig. 8F, green bars). We hypothesized that 
tumor cell avidity for exogenous CAF-derived mitochondria could be associated to a higher lactate 
exploitation. Notably, PC3 cells that have been reprogrammed by CAF-CM administration, increased their 
lactate uptake (Fig. 8G) and the lactate OXPHOS-dependent utilization, assayed by radioactive 14CO2 tracing 
(Fig. 8H), after the addition of CAF-derived mitochondria. This metabolic reprogramming exerted by CAF-
derived mitochondria supplementation leads to a higher activation of the described lactate-dependent SIRT1-
PGC1 axis: indeed, PC3 cells showed higher expression of MCT1, SIRT1 and PGC-1 levels (Fig. 8I) when 
exposed to CAF-derived mitochondria, thereby resulting in a significant increase in stroma-potentiated tumor 
invasive abilities (Fig. 8L). Crucially, we further evidenced that such stroma-to-tumor mitochondrial transfer 
is impaired by hindering lactate-dependent tumor:CAFs crosstalk by MCT1 inhibition (Fig. 8M). 
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Metabolic reprogramming is essential to satisfy the different cell requirements during tumor initiation 
and progression. Notably, such reprogramming is not merely influenced by cell-autonomous genomic 
alterations but also by non-genomic components and non-cell autonomous players, e.g. the tumor 
microenvironment. According to the so-called “two compartment” model of tumor metabolism [34], anabolic 
malignant cells can establish a metabolic symbiosis with the adjacent stromal catabolic cells to subtract high-
energy metabolites (e.g. lactate, glutamine, fatty acids) that can stimulate tumor proliferation and foster 
metastatic spreading [35]. Particularly, CAFs-derived lactate is the main driver for the enhancement of PCa 
cells malignancy, achieved by sustaining a complex metabolic and molecular rearrangement involving 
PKM2/miR-205/EMT partnership [3].  
Since OXPHOS metabolism was crucial to exploit the energy rich metabolites released by highly 
glycolytic stromal cells, we focused our attention on the mitochondrial rewiring that prostate carcinoma cells 
could undergo when in contact with the CAF secretome.  
Lactate released from CAF generates an unbalance in the NADH/NAD+ ratio of the PCa cells (Fig. 1). 
While NADH early increase could be due to the reversible activity (lactatepyruvate) and mitochondrial 
localization of the lactate dehydrogenase (LDH) [36], NAD+ subsequent high levels respond to the subsequent 
mitochondrial activation of stromal reprogrammed PCa cells, resulting in the SIRT1-mediated PGC-1α 
activation (a schematic model has been proposed in Fig. 8N). SIRT1 is a crucial “cog” in the molecular 
machine driving CAF-induced mitochondrial re-education of PCa cells. Indeed, the impairment of SIRT1 
function by a genetic approach counteracts EMT execution and invasiveness, through a clear impact on HIF-
1α stabilization. PGC-1α has been reported to have a crucial role in circulating breast cancer cells [8] and is a 
major driver of metastatic localization of breast cancer cells to the brain [37] and to the lung [38]. However, 
other studies have reported an opposite role, showing an association of PGC-1α downregulation with disease 
progression in PCa [9]. Notably, our CAF-exposed PCa model relies on the SIRT1-dependent acetylation of 
PGC-1α and not exclusively on its expression, possibly explaining the different roles of PGC-1α reported in 
these studies. Indeed, we argue that PGC-1α most likely reprograms and creates a new metabolic state that can 
either promote or hinder tumor growth and metastatic progression, depending on metabolic environment that 
exists within the primary and metastatic sites (i.e. circulating lactate). It is conceivable that when a cancer cell 
leaves the primary site to colonize secondary sites, PGC-1α deacetylation (i.e. activation) coordinates the 
bioenergetic profile of the circulating cancer cell, particularly reprogramming the mitochondrial status and 
activity, in order to have a high adaptability and plasticity for high-energy nutrients exploitation and ATP 
production to survive (when circulating) allowing to engraft in different secondary sites metabolic environment 
[39].  
In the model used in the current study, mtROS production and handling links the molecular 
rearrangements induced by CAF-conditioning to the metabolic reprogramming and finally to the phenotypical 
changes observed. Indeed, mtROS are established modulators of the metastatic cascade [24] and our data 
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clearly showed a CAFs-mediated mtROS generation, responsible for the oxidation of molecular mediators, i.e. 
Src and PKM2, crucial for sustaining the metabolic circuitry and EMT engagement in CAFs-exposed PCa 
cells. The concomitant mtROS generation and PGC-1α activation, a known driver of anti-oxidant response, 
seems controversial. However, PGC-1α could control redox homeostasis via different pathways. Indeed, 
mtROS triggers AMPK-PGC-1 signaling as feedback loop to limit potentially damaging levels of ROS [40]. 
Although we did not investigate NADPH levels and anti-oxidant response in our model, we can speculate that 
finely regulated mtROS levels could act as signaling molecules in the metabolic crosstalk between CAFs and 
PCa cells. Interestingly, mtROS scavenging is able to prevent PCa cells malignant rewiring and this may 
partially explain why mitochondria-targeted antioxidant drugs are effective in vivo to inhibit tumor metastasis 
[7, 24, 26], whereas broad-range antioxidants (e.g. N-acetyl-cysteine) tend to fail probably due to their inability 
to target and lower ROS generated and localized within the mitochondria [41].  
Lactate-dependent enhancement of mitochondrial function also influences TCA cycle intermediates, 
mainly increasing citrate, malate, succinate and fumarate. Such activation of OXPHOS metabolism in cancer 
cells in a lactate-dependent manner was recently supported by a study showing that circulating lactate can 
be used by tumor cells to fuel the TCA cycle [42]. The CAF-mediated increase succinate levels can be 
explained either by a TCA cycle overload and/or by a SDH activity dysfunction. We confirmed that CAF-CM 
impaired SDH expression and activity in PCa cells and leads to succinate accumulation, resulting in HIF-1α 
stabilization/activation and EMT execution, as reported in other models [43]. Similarly to succinate, fumarate 
promotes EMT signature in cancer cells, via epigenetic downregulation of miR-200ba429 [44].  
Besides the reported enhancement and reshaping of endogenous mitochondria upon CAF-CM 
exposure, for the first time we provide evidence about the ability of PCa cells to receive mitochondria from 
neighboring stromal cells, even in the absence of mitochondrial defects (i.e., mtDNA mutations).  
Growing evidence showed that reprogrammed stromal cells, undergoing glycolysis, display 
mitochondrial dysfunction and activate autophagy/mitophagy, which results in a series of stimuli ultimately 
leading to enhancement of the mitochondrial function of adjacent epithelial cancer cells [45, 46]. Here, we 
hypothesized that highly glycolytic CAFs could donate their dispensable mitochondria to neighboring PCa 
cells to improve their malignancy, concurring to strengthen the effect of soluble factors [19, 47] and/or 
exosomes [48]. According to our data, only few PCa cells are able to act as “receivers” for exogenous 
mitochondria. We hypothesize that during co-colture, paracrine signals govern the establishment of a 
“chemotactic-like force” generated by the receiver cells in guiding the tunneling nanotube formation and the 
unidirectional transfer of mitochondria. When CAF-derived mitochondria are administrated in the absence of 
CAFs:cancer cells contact, it is plausible that only few cells have been stimulated to act as “receiver” cells, 
hence only few cells could uptake exogenous mitochondria. In agreement with the idea that soluble secreted 
factors (e.g. CAF-released lactate) could influence cancer cells avidity towards external mitochondria, CAF-
CM pretreatment of cancer cells prior to CAF-derived mitochondria administration enhances the receiving 
capacity of cancer cells. We speculate that without this priming event, cancer cells are not prone to acquire 
exogenous mitochondria, but when they are primed to act as “receivers”, they can potentially accept 
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mitochondria independent on the “donors”. It is likely that within the prostate tumor microenvironment, only 
the cancer-reprogrammed highly glycolytic CAFs can act as “donor” cells of their dispensable mitochondria. 
On the contrary HPF, which still rely on a higher extent on mitochondrial metabolism, are not prone to deprive 
themselves of their mitochondria. 
Notably, CAFs-mediated mitochondrial transfer phenotypically acts on CAFs-reprogrammed PCa 
cells, presumably by selecting a subpopulation of cells characterized by enhanced invasive abilities, especially 
inclined to import and exploit CAF-secreted lactate, as reported by the MCT1 increased expression and lactate 
utilization in mitochondria-enriched PCa cells. It may be conceivable that the SIRT1/ PGC-1 pathway can 
be involved in mediating the increase in lactate upload in mitochondria receiver cells. It has been reported that 
in skeletal muscle cells, PGC-1 upregulates lactate uptake by increasing the expression of MCT1 [49]. In 
addition recent evidence reported that PGC-1enhances the expression and activation of lactate 
dehydrogenase B (LDH-B), which drives the conversion of lactate to pyruvate, while repressing the LDH-A 
activity, thus resulting in the enhancement of lactate consumption [50]. Independently on the primum movens, 
whether this transfer of mitochondria is a rare event or a highly impacting phenomenon to improve cancer 
malignancy and whether this process has clinical relevance is still unknown and require additional 
investigation.  
Taken together, our data suggest that the CAF-derived secretome confers to PCa cells a previously 
unexplored function, driving the activation of a SIRT1/PGC-1α axis that is responsible for enhancement of 
mitochondrial function and, in turn, for mtROS generation and oncometabolite accumulation. All these events 
concur to enhance the migratory and metastatic abilities of PCa cells. Particularly, our findings reveal that 
glycolytic CAFs directly transfer their functional but underexploited mitochondria to cancer cells, further 
promoting mitochondrial utilization and OXPHOS-addiction of PCa cells, and ultimately promoting their 
malignancy.  
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MATERIALS AND METHODS 
 
Cell lines, antibodies and reagents 
Human PCa cells (PC3, DU145) were obtained and authenticated by PCR/short tandem repeat (STR) analysis 
from ATCC and maintained at 37°C/5% CO2 in DMEM supplemented with 10% fetal bovine serum (FBS), 2 
mM L-Glutamine and 1% penicillin/streptomycin. Human prostate fibroblasts (HPFs and CAFs) were isolated 
from surgical explants after patient informed consent, according to the Ethics Committee of the Azienda 
Ospedaliera Universitaria Careggi (Florence, Italy). Unless specified otherwise, all reagents were obtained 
from Sigma-Aldrich. The following antibodies were used in this study: rabbit E-Cadherin (#5296) and rabbit 
PKM2 (#4053) from Cell Signaling Technology, mouse HIF-1α (#610958) from BD Biosciences, rabbit total 
OXPHOS cocktail (ab110411) and rabbit acetyl lysine (ab80178) from Abcam, mouse SIRT1 (sc-74504), 
mouse MCT1 (sc-365501), rabbit PGC-1α (sc-13067), mouse vimentin (sc-6260), rabbit c-Src (sc-19) and 
mouse b-actin (sc-58673) from Santa Cruz Biotechnology, Inc. Secondary antibodies were from Santa Cruz 
Biotechnology, Inc. MitoTEMPO (sc-221945) was from Santa Cruz Biotechnology, Inc and MCT1 inhibitor 
AR-C155858 (#4960) was from Tocris BioScience. 
Conditioned media from fibroblasts  
HPFs and CAFs were grown to subconfluence and treated for 48 hours with serum-free medium to obtain the 
corresponding CM. PCa cells were treated with CM collected from fibroblasts (HPFs or CAFs) for 24 or 48 
hours.  
Plasmid and siRNA transfection 
Cells were transfected with siSIRT1 and siPGC-1α or negative controls (Santa Cruz Biotechnology) or with 
mitochondria-targeted plasmids mt-HA-eGFP, AT-F001-D and mtDsRed, AT-F002-D (Aequotech srl) using 
Lipofectamine RNAi-Max Reagent or Lipofectamine 3000 (Thermo Fisher Scientific), respectively. Analyses 
were performed 3 days after transfection. For mitochondria tracking in vivo, CAFs were infected with lentiviral 
particles containing the pLJM1-EGFP plasmid. 
NAD+/NADH measurement 
Intracellular NAD(H) content was quantified by means of an enzymatic cycling procedure according to [51].  
Measurement of oxygen consumption rate (OCR) 
PCa cells (PC3, DU145) were maintained at 37 °C and oxygen consumption was measured using a Clark-type 
O2 electrode (Hansatech). The rate of decrease in oxygen content, related to cell number, was taken as index 
of the respiratory ability.  
Mitochondrial staining and mitochondrial reactive oxygen species (mtROS) analysis 
MitoTracker Green, TMRE and MitoSOX were used accordingly to manufacturers’ instructions (Invitrogen). 
Cwll were analyzed by flow cytometry using FACScan flow cytometer (BD Biosciences) or by confocal 
imaging (Leica TCS SP5). 
SDH activity 
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Cell homogenates were incubated in a phosphate buffer containing sodium azide, 2,6 dichlorophe- 
nolindophenol (DCPIP), sodium succinate, and phenazine methosulfate. SDH specific activity was measured 
by photometry using the Victor3 1420 Multilabel Counter (Packard Instruments, Perkin-Elmer) to measure the 
decrease in absorbance that resulted from the oxidation of DCPIP at 600 nm. 
Radioactive assays 
PCa cells were treated as described in the Figures and subjected to radioactive assays as described previously 
[2]. 
Confocal image acquisition and analysis 
Cells were stained with TMRE, DAPI or MitoTracker Green dye or transfected with fluorescence-tracked 
plasmids (mt-HA-eGFP,and mtDsRed, AT-F002-D). Fluorescence samples were examined using a 
microscope (TCS SP5; Leica) as described in detail in Supplementary Material and Methods. Fluorescence 
quantification and 3D reconstruction were assessed using ImageJ and Imaris Bitplane software, respectively.  
Mitochondria isolation and transfer to recipient cells 
Mitochondria were prepared using a modified protocol described in [52]. For a detailed procedures, see 
Supplementary Material and Methods. 
Immunoprecipitation, immunoblotting and BIAM labeling 
Cells were lysed in RIPA buffer and subjected to immunoprecipitation and/or Western blot as described 
previously [3]. Detection of protein redox state, was performed as described in [53]. Briefly, at the end-point 
of the experiment, PC3 cells were frozen rapidly in liquid nitrogen and exposed to oxygen-free RIPA Buffer 
containing 100 mM of N-(biotinoyl)-N0-(iodoacetyl) ethylenediamine (BIAM). After sonication, cell lysates 
were incubated for 15min at room temperature. Lysates were then clarified by centrifugation and 500 mg of 
each sample subjected to immunoprecipitation with c-Src or PKM2-specific antibodies. BIAM-labelled 
immunocomplexes were separated by SDS-PAGE and the biotinylated/reduced fraction of the 
immunoprecipitated proteins was revealed with Horseradish Peroxidase-conjugated streptavidin. 
In vitro Boyden invasion assay 
Motility and invasion assays were conducted as described previously [3]. 
TCA cycle metabolites quantification by HPLC-ESI-MS  
PC3 cells (5 x 106 cells/condition) were homogenized in water, added to methanol and chloroform, centrifuged 
and the aqueous layer was recovered. After addition of cold acetone, suspensions were centrifuged and 
supernatants used for HPLC-MS analysis using an LTQ Orbitrap mass spectrometer coupled to and Accela 
HPLC system (Thermo Fischer Scientific). For a detailed procedures, see Supplementary Material and 
Methods.  
Determination of PHD2 and HIF-1 activities  
Dual luciferase reporter assays were performed with the dual luciferase kit (Promega) using pGL3-(PGK-
HRE6)-TK-Luc as reporter of HIF-1 activity. Reporter plasmid and a Renilla transfection normalization vector 
(Promega) were used. 
Xenograft experiments 
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In vivo experiments were conducted in accordance with national guidelines and approved by the ethical 
committee of Animal Welfare Office of Italian Work Ministry and conform to the legal mandates and Italian 
guidelines for the care and maintenance of laboratory animals. Six- to 8-week-old male severe combined 
immunodeficient (SCID)-bg/bg mice (Charles River Laboratories International) were s.c. injected with 1 × 106 
PC3 cells or mixed with 0.5 × 106 of fibroblasts for co-injection. For cell tracking and mitochondria transfer 
experiments, PC3 TdTomato and MitoGFP fibroblasts were used. 
Immunohistochemistry on tissue specimens 
IHC was performed on 14 paraffin-embedded and serially cut prostate cancer tissues obtained from Azienda 
Ospedaliera Universitaria Careggi, Florence, following patient consent and approval from the local Ethics 
Board. For all the histological samples the Gleason Grade and the pathological T staging were defined. The 
cases included in the study were divided in two groups according to histologic features: 1) prostatic 
adenocarcinoma, acinar type, Gleason score 3+3=6, grade group 1, stage pT2, pN0; 2) prostatic 
adenocarcinoma, acinar type, Gleason score 4+3=7, pattern 4: 70-80%, grade group 3, stage pT3b, pN1. 
IHC staining was performed using the following antibodies: MCT1 (H-1), mouse monoclonal antibody (Santa 
Cruz Biotecnology) and SIRT1 (B-10), mouse monoclonal antiboby (Santa Cruz Biotecnology) on a Ventana 
BenchMark ULTRA immunostainer (Ventana Medical Systems, Tucson, AZ). For semiquantitative 
assessment of the IHC data, the mean percentage of positive tumor cells was determined at 400X magnification 
for each section and evaluated in a blinded manner. Sections were graded on the basis of the intensity of 
staining as 0 (negative), 1 (weak), 2 (moderate), or 3 (strong). 
Tumor dissociation and ex vivo culture 
Briefly, mice were sacrificed when tumors reached 0.5 cm3. Excised tumors were minced into 2-4 mm 
fragments, which were then incubated for 2h with the dissociation solutions containing 200 U/ml collagenase 
III, IV and Hyaluronidase. Digested fragments were filtered (70 μm cell strainer) and released cells were 
freshly analyzed. 
Statistical analysis 
Statistical analysis was performed with Prism software (GraphPad Software). Data show means +/- SEM from 
at least three independent biological replicates (indicated as “n”). Comparisons between groups were analyzed 
by t-test or one-way/two-way analysis of variance (ANOVA) followed by post-hoc test. Statistical significance 
was considered when p<0.05.  
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Figure 1. CAFs conditioning triggers a lactate-dependent SIRT1/PGC-1α axis activation in PCa cells. 
PC3 cells were cultured with conditioned medium (CM) from HPF or CAF for 24, 48 or 72 hours. A. Time-
point of NADH (left plot) and NAD+ (right plot) values, normalized on protein content, have been plotted. 
Data represent mean ± SEM, n = 3. ns, no significant *P < 0.05, by two-tailed t test. B. Total cell lysates or 
PGC-1α immunoprecipitates (IP) were subjected to Western blot (WB) analysis as indicated. C. Pearson’s 
correlation scatter plot of the NAD+ levels and acetylation status of PGC-1α in PC3 cells treated with CAF-
CM for 48 h. D. NADH and NAD+ normalized levels.  PC3 cells were exposed to HPF-CM, CAF-CM or 
10mM lactate for 24h, with or without MCT1 inhibitor (AR-C155858, 10µM) administration to. E. PC3 cells 
were treated for 16 h  in glucose/pyruvate/glutamine-free medium (‘no nutrients’, used as positive control) and 
10 mM lactate, 2 mM glutamine, 1 mM pyruvate and 25 mM glucose where then administered for 24 h. SIRT1 
expression was assessed by WB. F. SIRT1 expression and PGC-1 acetylation were assessed on PC3 cell 
lysates and PGC-1 IP, respectively. Quantification analysis of acetylation and SIRT1 expression was relative 
to their respective controls (the fold change numbers were indicated).  
Figure 2. CAFs promote a functional rewiring of mitochondria in PCa cells. A-C. Mitochondrial 
membrane potential (TMRE) and mitochondrial mass (MitoTracker Green) of PCa cells were measured by 
FACS analysis after 48 hours treatment with HPF- or CAF-CM. Confocal images of TMRE/DAPI-stained 
cells were also shown, with the corresponding quantification plot. Scale bar, 5 µm (E). D. Measurement of 
oxygen consumption rate (OCR, pmol O2/min/cells) in PCa cells, exposed to HPF-CM or CAF-CM for 48 
hours. Data represent mean ± SEM, n = 3.  ns, no significant, *P < 0.05; **P < 0.005; ***P < 0.001, by two-
tailed t test. E. LC-MS analysis of the TCA cycle metabolites. Data were represented as percentage compared 
to the control. n = 3. ns, no significant, *P < 0.05; **P < 0.005; ***P < 0.001, by two-tailed t test. 
Figure 3. CAFs-mediated SIRT1/PGC-1α axis activation is crucial for invasive traits of PCa cells.  
PC3 or DU145 cells were silenced with non-targeting control (siCTR) and siRNA targeting SIRT1 or PGC-
1, then treated with HPF-CM or CAF-CM for 48 hours.  A-B. PC3 cells silenced for SIRT1 were subjected 
to western blot (A) and invasion assay (B). C-E. PC3 cells silenced for PGC-1α and treated as in A were 
subjected to western blot (C), invasion assay (D) and TMRE analysis (E). Scale bar, 5 µm. TMRE fluorescence 
was quantified as signal measured per cell (E). Data represent mean ± SEM, n = 3. ns, no significant, *P < 
0.05; **P < 0.005; ***P < 0.001, by two-tailed t test. F-G. Measurement of OCR and TCA cycle intermediates 
in PCa cells silenced for SIRT1 and exposed to HPF-CM or CAF-CM for 48 hours. Quantification analysis of 
protein levels in WB was relative to their respective control (the fold change numbers were indicated). 
Figure 4. CAFs-promoted TCA cycle intermediates accumulation affects HIF-1-mediated invasive 
features. 
A-B. Analysis of ETC complexes expression by WB (A) and SDH activity (B) by enzymatic assay, in PC3 
cells exposed to HPF- or CAF-CM for 48 hours. Mean ± SEM, n = 3.  ***P < 0.001, by two-tailed t test. D. 
Analysis of HIF-1α expression in 48 hours CAF-CM-exposed PC3 cells upon impairment of lactate import 
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through MCT1 inhibitor treatment. E-F. HIF-1α expression and activity were respectively determined by WB 
and HRE luciferase assay in PC3 cells treated with α-KG at the indicated concentration for 48 hours. G-H. E-
cadherin levels and cell invasion were measured in α-KG-treated (1mM) PC3 cells. Data represent mean ± 
SEM, ns, no significant, p>0.05, *P < 0.05; **P < 0.005; ***P < 0.001, by one-way ANOVA, with Tukey post 
hoc tests. 
Figure 5. CAFs contact promotes mtROS accumulation sustaining motile features and SIRT1/PGC-
1activation in PCa cells. 
A. Evaluation of mtROS content by FACS analysis in PC3 and DU145 cells, after 48 hours treatment with 
HPF- or CAF-CM. B. PC3 cell invasion performed with or without MitoTEMPO administration (50 µM). C-
D Evaluation of NAD+/NADH ratio (C) and PGC1-α acetylation status (D) in redox-insensitive Src mutants-
transfected PC3 cells treated as in A. Mean ± SEM, n = 3. ns, no significant, p>0.05; *P < 0.05, by one-way 
ANOVA, with Tukey post hoc tests. E. Evaluation of mtROS content in PC3 cells silenced for SIRT1 and 
exposed to HPF- or CAF-CM. Data represent mean ± SEM, n = 3. ns, no significant, p>0.05; *P < 0.05; **P 
< 0.005, by two-tailed t test. 
Figure 6. CAFs mediate horizontal transfer of mitochondria to PCa cells. 
A-B. CAFs-to-PCa cells mitochondria transfer analyzed by confocal microscopy. The transfer was quantified 
through the acquisition of MitoTracker Green labelling in unlabeled PC3 (A) or DU145 cells (B) after a 24 
hours coculture with MitoTracker Green-stained CAFs. C. FACS analysis of acceptor cell populations (1) 
acquiring MitoTracker Green staining from donor cell population (2) in co-culture between CAFs and 
TdTomato fluorescent PC3 cells. Monoculture was used as comparator. Mean ± SEM in (C), n = 3. ns, no 
significant, **P < 0.05, by one-way ANOVA, with Tukey post hoc tests. Scale bar, 10 µm. D. Representative 
images of mitochondria transfer from CAFs transfected with mitochondria-targeted plasmids (MitoDsRed) to 
GFP-tracked PC3 cells after 24 h of co-colture. Scale bar, 10 µm. E. Representative images of TMRE staining 
upon 24 hours of MitoGFP-tracked CAF:unlabeled PC3 cells of co-culture. Scale bar, 10 µm; dashed lines 
indicate selected area for 63X zoom of TMRE/MitoGFP-loaded PC3 cell.  
Figure 7. In vivo transfer of mitochondria from CAFs to PCa cells. 
A. Schematic model of the experimental setting. B-C. FACS and confocal analysis showing the acquisition of 
labelled mitochondria derived from MitoGFP-infected CAFs by TdTomato-fluorescent PC3 cells recovered 
after tumor disaggregation. DAPI was used to stain nuclei. Scale bar, 10 µm.  D-F. Mitochondrial mass and 
mitochondrial membrane potential were measured in PC3 cells derived from disaggregated tumors by FACS 
or confocal analysis upon MitoTracker Green or TMRE staining, respectively. Scale bar, 10 µm. G. Expression 
of MCT1, SIRT1 and E-cadherin in PC3 cells derived from disaggregated tumors (#1 and #2 are relative to 
tumors excised from two different mice). Data represent mean ± SEM, n = 3. **P < 0.05; **P < 0.005, by 
two-tailed t test. H. Representative IHC analysis of MCT1 and SIRT1 in low-grade (grade group 1) and high-
grade (grade group 3) prostate tumors and relative quantification per intensity of staining scoring. Data shown 
are from 7 samples per group ± SEM, Student t test. Scale bar, 200 m. Magnification (40X) of highlighted 
areas was shown below. 
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Figure 8. Transferred mitochondria from CAFs enhance motile features and lactate metabolism of PCa 
cells. 
A-B. Two representative images of tunnelling structures mediating mitochondria transfer from MitoGFP-
transfected CAFs toward PC3 or DU145 cells. Scale bar, 10 µm. C. Schematic model for the 24 hours -
administration of CAFs-isolated mitochondria to PC3 cells (previously treated with HPF- or CAF-CM for 48h) 
or to CAFs (1µg mitochondria/1.5x105 cells). D. Fluorescence images showed MitoTracker Green dots as 
readout of mitochondria uptake in the indicated cell types (PC3, CAF) and treatments (HPF- or CAF-CM). 
Scale bar, 10 µm. Mean fluorescence inside cells was measured and plotted. E. Internalization of mitochondria 
was confirmed by confocal z sections in pre-labeled OrangeRed PC3 cells acquiring MitoTracker Green-
labeled CAF mitochondria. Scale bar, 10 µm.  F. Evaluation of mtROS by FACS analysis in PC3 cells treated 
as above; green bars are representative for the percentage of PC3 cells acquiring CAF-derived MitoTracker 
Green-labeled mitochondria. Mean ± SEM, n = 3. **P < 0.05; **P < 0.005, by two-tailed t test. G-H. 
Evaluation of lactate uptake (G) and CO2 release (H) by using radiolabeled 14C-(U)-lactate in PC3 cells, 
exposed to HPF- or CAF-CM (48 hours), upon CAF mitochondria administration (24 hours). Mean ± SEM, n 
= 3. **P < 0.05; **P < 0.005, by two-tailed t test. I-L. Western blot analysis for MCT1, SIRT1 and PGC-1α 
expression (I) and invasion assay (L), performed on PC3 cells, treated for 48 hours with HPF- or CAF-CM 
and subsequently exposed to CAF mitochondria for 24 hours. Mean ± SEM, n = 3. **P < 0.05; **P < 0.005, 
by two-tailed t test. M. FACS analysis showing the inhibition of mitochondria transfer from MitoDsRed-
transfected CAFs to GFP expressing-PC3 cells, upon impairment of lactate influx by 24 hours MCT1 inhibitor 
(AR-C155858) treatment (10µM). Data represent mean ± SEM, n = 3. **P < 0.05; **P < 0.005; #P< 0.05; 
##P<0.005 between mitochondria-loading PC3 cell populations, by two-tailed t test. N. Graphical scheme 
depicting the model of the prostate tumor-stroma metabolic interaction. CAFs potentiates PCa cell 
mitochondria by activating the lactate/SIRT1/PGC1-α axis and by supplying their own functional 
mitochondria to boost the oxidative metabolism of PCa cells. The subsequent OXPHOS engagement of PCa 
cells is associated to EMT and to a more invasive phenotype. 
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Figure S1. CAF-induced SIRT1/PGC-1α axis affects EMT and mitochondrial metabolism in
PCa cells.
(A) Normalized NAD+ and NADH levels were assessed in PC3 cells, by replenishing (r) or adding (a) 
HPF-CM  or CAF-CM every 24 h, as depicted in the experimental setting above. Mean ± SEM in (C), n = 3. 
ns, no significant, **P < 0.05, by one-way ANOVA, with Tukey post hoc tests. (B) Immunoprecipitation and 
acetylation status of PGC-1α were assessed in PC3 silenced for SIRT1 and treated with HPF- or CAF-CM, 
as indicated. (C) Total lysates from DU145 cells silenced for SIRT1 were subjected for WB analysis. (D) 
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Figure S2. CAFs-induced mtROS generation drives Src/PKM2 oxidation and altering such redox status 
impairs CAF-associated EMT engagement in prostate cancer cells. 
(A) Representative images of mtROS levels in PC3 cells exposed to HPF- or CAF-CM. mtROS were evaluated 
by MitoSOX staining and analyzed by confocal fluorescence analysis. Scale bar, 10 μm. B-C. E-cadherin 
expression and Src/PKM2 oxidation were assessed in prostate cancer cells by WB analysis on total cell lysates 
or Src/PKM2 immunoprecipitations from BIAM-treated lysates, respectively. MitoTEMPO was used as mtROS 
scavenger. Quantification plots of E-cadherin and streptavidin signals normalized on actin, c-Src or PKM2 from 
three independent experiments were shown. (D) Normalized NAD+ and NADH levels were assessed in PC3 
cells, transfected with redox-insensitive Src mutants, and then exposed to HPF- or CAF-CM for 24 h and 48 h. 
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Supplementary Figure 3
Figure S3. HPF cocultered with PC3 and DU145 cells do not supply own mitochondria.
Representative images of HPFs labeled with MitoTracker Green cocultered with unstained PCa cells, indicated 
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